Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

9.1%

1 terminated out of 11 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

9%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

67% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (9)
P 3 (1)

Trial Status

Recruiting5
Completed2
Active Not Recruiting2
Enrolling By Invitation1
Terminated1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (11)

Showing 11 of 11 trials
Showing all 11 trials

Research Network

Activity Timeline